Some pharmacokinetic parameters of salvianolic acid A following single-dose oral administration to rats.
CONCLUSIONS: These results support the future development of Sal A as an oral drug for the treatment of diabetic complications. Future research should be conducted to investigate the reason for its poor bioavailability and improve this situation.
PMID: 30122142 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: Bile | Biology | Brain | Diabetes | Drugs & Pharmacology | Endocrinology | Liver | Neurology | Study | Urology & Nephrology